Every blockbuster new drug starts as hundreds of hours in the lab and behind the computer screen. Join us to get a window into that painstaking, sometimes painful process. What mechanisms are getting new attention? How is technology changing the process? We’re tracking the journey from bench to clinic.
We’ll kick off with a free virtual program in the morning, then shift to an intimate happy hour and in-person only fireside chat at Row 34 in Cambridge. Ticket required for the happy hour.
Morning SessionS
- 11:00 AM - 11:25 AM ET Beyond CRISPRvirtual
- 11:30 AM - 11:50 AM ET Entering the virtual lab with Stanford’s James Zou virtual
- 11:55 AM - 12:20 PM ET Alzheimer’s and the blood-brain barriervirtual
- 12:25 PM - 12:55 PM ET The intelligence layer: Preparing your organization for AI-driven sciencevirtual
- 1:00 PM - 1:25 PM ET From discovery to delivery: Getting medicines to the patients who need themvirtual
Join us online for an editorial briefing hosted by Endpoints journalists and guests.
Afternoon Sessions + HAPPY HOUR
After the virtual programming wraps, the conversation continues in person. Join Endpoints editors and invited guests in Boston for a fireside chat and happy hour.
- 6:00 PM - 8:00 PM ET Happy hour in-person only
- 6:30 PM - 7:00 PM ET In conversation with Aurora Therapeutics CEO Ed Kaye in-person only
Choose your pass
Join the virtual conversation — or upgrade to the full, in-person experience in Boston.
- Access to morning virtual programming
- Post-event access to on-demand recordings
- Only 65 tickets available
- Live fireside chat (in person only)
- Happy hour with open bar and light snacks
- Access to morning virtual programming and post-event recordings
Venue
Row 34 Cambridge
314 Main Street, Cambridge, MA
314 Main Street, Cambridge, MA
In the heart of Kendall Square, just steps from the labs and offices shaping the future of biotech, Row 34 Cambridge provides an intimate backdrop for our in-person happy hour and fireside conversation. Gather for drinks, light bites, and thoughtful discussion with fellow leaders across the life sciences.


